General Information of Drug (ID: DMU8TH5)

Drug Name
Dibenzoylmethane Drug Info
Synonyms Dibenzoylmethane (chronic inflammatory disease/cancer)
Cross-matching ID
PubChem CID
8433
ChEBI ID
CHEMBL371523
CAS Number
CAS 120-46-7
TTD Drug ID
D02BDL

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Staphylococcus aureus infection 2.46 0.00e+0 72/95 (75.79%) CFH;DEFB1;C1QB;...
Systemic lupus erythematosus 2.26 0.00e+0 45/135 (33.33%) C1QB;C1R;HLA-DPB1;...
Complement and coagulation cascades 2.18 0.00e+0 76/85 (89.41%) CLU;CFH;CD59;...
Allograft rejection 2.12 0.00e+0 32/38 (84.21%) HLA-DPB1;HLA-DPA1;HLA-DQB1;...
Viral protein interaction with cytokine and cytokine re... 2.11 0.00e+0 84/100 (84%) CXCL14;CXCL9;CCL19;...
Retinol metabolism 2.01 1.31e-3 41/68 (60.29%) ALDH1A1;UGT2B28;DHRS9;...
Type I diabetes mellitus 1.95 3.36e-3 38/43 (88.37%) PTPRN2;HLA-DPB1;HLA-DPA1;...
Primary immunodeficiency 1.91 4.91e-3 33/38 (86.84%) LCK;CD8A;TAP1;...
NF-kappa B signaling pathway 1.89 4.36e-3 90/104 (86.54%) TLR4;CD14;CCL19;...
Asthma 1.87 3.92e-3 25/31 (80.65%) HLA-DPB1;HLA-DPA1;HLA-DQB1;...
Antigen processing and presentation 1.81 8.56e-3 60/78 (76.92%) HLA-DPB1;HLA-DPA1;CD8A;...
Th1 and Th2 cell differentiation 1.78 1.37e-2 80/92 (86.96%) HLA-DPB1;LCK;HLA-DPA1;...
Metabolism of xenobiotics by cytochrome P450 1.78 1.33e-2 49/77 (63.64%) CBR3;UGT2B28;GSTA4;...
Autoimmune thyroid disease 1.76 1.29e-2 46/53 (86.79%) HLA-DPB1;HLA-DPA1;HLA-DQB1;...
Pyrimidine metabolism 1.76 1.26e-2 40/56 (71.43%) NT5E;CDA;NME3;...
Phagosome 1.72 1.62e-2 118/152 (77.63%) TLR4;CD14;CYBB;...
Leishmaniasis 1.71 2.03e-2 67/77 (87.01%) TLR4;CYBB;HLA-DPB1;...
Pentose and glucuronate interconversions 1.68 2.49e-2 17/34 (50%) UGT2B28;AKR1B10;UGT2B15;...
Cytokine-cytokine receptor interaction 1.68 2.35e-2 246/295 (83.39%) CXCL14;CXCL9;CCL19;...
Intestinal immune network for IgA production 1.68 2.32e-2 38/48 (79.17%) HLA-DPB1;HLA-DPA1;HLA-DQB1;...
Cell adhesion molecules 1.67 2.58e-2 118/148 (79.73%) VCAM1;HLA-DPB1;CD2;...
Rheumatoid arthritis 1.66 2.64e-2 78/93 (83.87%) TLR4;HLA-DPB1;LTB;...
Graft-versus-host disease 1.64 3.04e-2 32/42 (76.19%) HLA-DPB1;HLA-DPA1;HLA-DQB1;...
Hematopoietic cell lineage 1.63 3.07e-2 90/99 (90.91%) CD59;CD14;IL1R2;...
Steroid hormone biosynthesis 1.62 3.42e-2 43/61 (70.49%) UGT2B28;UGT2B15;HSD17B2;...
Pertussis 1.62 3.38e-2 64/76 (84.21%) TLR4;CALML5;CD14;...
Proteasome 1.60 3.66e-2 44/46 (95.65%) PSMB8;PSMB9;PSME1;...
Inflammatory bowel disease 1.60 3.62e-2 58/65 (89.23%) TLR4;HLA-DPB1;TLR2;...
Ascorbate and aldarate metabolism 1.59 3.76e-2 15/30 (50%) UGT2B28;UGT2B15;ALDH2;...
Relaxin signaling pathway -1.78 3.25e-2 114/129 (88.37%) ADCY6;ADCY2;COL4A4;...
Central carbon metabolism in cancer -1.80 3.66e-2 67/70 (95.71%) PGAM1;PFKP;MAP2K2;...
GABAergic synapse -1.81 3.96e-2 76/89 (85.39%) PLCL1;GABRD;ADCY6;...
Glycine, serine and threonine metabolism -1.82 4.06e-2 31/40 (77.5%) CBS;PGAM1;PSAT1;...
Alanine, aspartate and glutamate metabolism -1.85 4.88e-2 27/37 (72.97%) GFPT1;GOT1;ABAT;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Osteosarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
U-2 OS CVCL_0042 Homo sapiens 10uM 6H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 10uM 6H, 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 10uM 6H, 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 10uM 6H, 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 10uM 6H, 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC515 CVCL_5134 Homo sapiens 10uM 6H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 10uM 6H, 24H
VCaP CVCL_2235 Homo sapiens 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 10uM 6H, 24H